Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemiaLuca Baldini, EE Polli, R. Mozzana et al.|Blood|1985Cited by 48
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.Giorgio Lambertenghi‐Deliliers, Polli Ee, C. Annaloro et al.|PubMed|1989Cited by 12
A CooDerative Studv on ProMACE-dytaBOM in Aggressive Non-Hodgkin's LymphomasEdmondo Cassi, Giorgio Lambertenghi‐Deliliers, R. Mozzana et al.|Leukemia & lymphoma/Leukemia and lymphoma|1994Cited by 7
EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease.Enrico Maria Pogliani, Edmondo Cassi, Luca Baldini et al.|PubMed|1996Cited by 3
Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)Paola Tacchetti, Michèle Cavo, Carolina Terragna et al.|Blood|2011Cited by 1